BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11509325)

  • 1. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin.
    Oury TD; Thakker K; Menache M; Chang LY; Crapo JD; Day BJ
    Am J Respir Cell Mol Biol; 2001 Aug; 25(2):164-9. PubMed ID: 11509325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats.
    Sogut S; Ozyurt H; Armutcu F; Kart L; Iraz M; Akyol O; Ozen S; Kaplan S; Temel I; Yildirim Z
    Eur J Pharmacol; 2004 Jun; 494(2-3):213-20. PubMed ID: 15212977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcription factor NRF2 protects against pulmonary fibrosis.
    Cho HY; Reddy SP; Yamamoto M; Kleeberger SR
    FASEB J; 2004 Aug; 18(11):1258-60. PubMed ID: 15208274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor.
    Pini A; Viappiani S; Bolla M; Masini E; Bani D
    J Pharmacol Exp Ther; 2012 May; 341(2):493-9. PubMed ID: 22344408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study.
    Chitra P; Saiprasad G; Manikandan R; Sudhandiran G
    Toxicol Lett; 2013 May; 219(2):178-93. PubMed ID: 23523906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats.
    Yildirim Z; Kotuk M; Erdogan H; Iraz M; Yagmurca M; Kuku I; Fadillioglu E
    J Pineal Res; 2006 Jan; 40(1):27-33. PubMed ID: 16313495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
    Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
    Nici L; Santos-Moore A; Kuhn C; Calabresi P
    Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MnTBAP Inhibits Bleomycin-Induced Pulmonary Fibrosis by Regulating VEGF and Wnt Signaling.
    Venkatadri R; Iyer AK; Ramesh V; Wright C; Castro CA; Yakisich JS; Azad N
    J Cell Physiol; 2017 Mar; 232(3):506-516. PubMed ID: 27649046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats.
    Iraz M; Erdogan H; Kotuk M; Yağmurca M; Kilic T; Ermis H; Fadillioğlu E; Yildirim Z
    Pharmacol Res; 2006 Mar; 53(3):310-6. PubMed ID: 16459098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
    El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G
    Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A TSP-1 synthetic peptide inhibits bleomycin-induced lung fibrosis in mice.
    Chen Y; Wang X; Weng D; Tian L; Lv L; Tao S; Chen J
    Exp Toxicol Pathol; 2009 Jan; 61(1):59-65. PubMed ID: 18579356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of nuclear factor erythroid 2-related factor 2 via extracellular signal-regulated kinase contributes to bleomycin-induced oxidative stress and fibrogenesis.
    Liu R; Chen H; Bai H; Zhang W; Wang X; Qin X; Zhang X; Li W; Liang X; Hai C
    Toxicol Lett; 2013 Jun; 220(1):15-25. PubMed ID: 23570914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats.
    Verma R; Brahmankar M; Kushwah L; Suresh B
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):769-78. PubMed ID: 23958969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of bleomycin-induced pulmonary fibrosis in the hamster by cis-4-hydroxy-l-proline.
    Riley DJ; Kerr JS; Berg RA; Ianni BD; Pietra GG; Edelman NH; Prockop DJ
    Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):388-93. PubMed ID: 6164320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
    Gurujeyalakshmi G; Wang Y; Giri SN
    J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis.
    Martins V; Valença SS; Farias-Filho FA; Molinaro R; Simões RL; Ferreira TP; e Silva PM; Hogaboam CM; Kunkel SL; Fierro IM; Canetti C; Benjamim CF
    J Immunol; 2009 May; 182(9):5374-81. PubMed ID: 19380784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG).
    Molina V; Haj-Yahia S; Solodeev I; Levy Y; Blank M; Shoenfeld Y
    Autoimmunity; 2006 Dec; 39(8):711-7. PubMed ID: 17178568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
    Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
    J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.